Search results
Dong Shen, M.D., Ph.D. — Chief executive officer Dr. Shen graduated with PhD degree from Johns Hopkins University School of Medicine and MD degree from Shanghai Jiao Tong University School of Medicine. Dr. Shen has extensive drug development experience in AstraZeneca and Johnson and Johnson, having led projects across multiple therapeutic areas with high unmet medical need. He has held leadership across early and late programs in the areas of infectious disease, oncology and rare disease ...
2013. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. JE Churpek, K Pyrtel, KL Kanchi, J Shao, D Koboldt, CA Miller, D Shen, ... Blood, The Journal of the American Society of Hematology 126 (22), 2484-2490.
Sep 24, 2020 · Dong Shen, M.D., PhD., graduated from Johns Hopkins University School of Medicine, is the founder and CEO of RNAimmune. Headquartered in Gaithersburg, MD, RNAimmune’s messenger RNA proprietary technology is used to
: Anesthesia-induced cognitive impairment may depend on developmental stage, anesthetic agent, and number of exposures. These findings also suggest the cellular basis and the potential prevention and treatment strategies for anesthesia-induced cognitive impairment, which may ultimately lead to safer …
| | | | | | | CURRENT MEMBERs PAST MEMBERs
Mar 2, 2022 · Dominant Processes of HONO Derived from Multiple Field Observations in Contrasting Environments Ying Jiang , Likun Xue* , Hengqing Shen* , Can Dong , Zhisheng Xiao , and Wenxing Wang
BIOHK2023 is an international convention organized by HKBIO to introduce novel state-of-the-art biotech innovations from around the globe, with the purpose of providing an extensive platform to allow pioneers of the biotech industry to convene. From infectious diseases like COVID-19, to the latest cancer treatments and diagnostics to big data analytics, BIOHK2023 is an unparalleled event covering the most relevant and timely topics in biotechnology. Don't miss this opportunity to be at the ...
